alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
** **

**Exhibit 12.1**

 

**Hospira, Inc.**

 

**Computationof Ratio of Earnings to Fixed Charges**

 

**(Unaudited)**

 

***(dollars in millions except ratios)***

*** ***

| ** **                                                    | ** ** | **Three Months  Ended  March 31, 2009** | ** ** |
|---------------------------------------------------------------|------------|--------------------------------------------------------|------------|
| Income from Continuing Operations Before Taxes                |       | $                                                      | 88.1       |   |
| Add:                                                          |       |                                                   |       |
| One-third of rents                                            |       | 2.1                                                    |       |
| Interest on long-term and short-term debt                     |       | 26.9                                                   |       |
| Interest capitalized, net of amortization                     |       | 0.1                                                    |       |
|                                                          |       |                                                   |       |
| Earnings from Continuing Operations                           |       | $                                                      | 117.2      |   |
|                                                          |       |                                                   |       |
| Fixed charges:                                                |       |                                                   |       |
| One-third of rents                                            |       | $                                                      | 2.1        |   |
| Interest on long-term and short-term debt                     |       | 26.9                                                   |       |
| Interest capitalized                                          |       | 1.4                                                    |       |
|                                                          |       |                                                   |       |
| Fixed Charges from Continuing Operations                      |       | $                                                      | 30.4       |   |
|                                                          |       |                                                   |       |
| Ratio of Earnings to Fixed Charges from Continuing Operations |       | 3.9                                                    |       |

 

For purposes of computingthis ratio, “earnings” consist of income from continuing operations beforetaxes, one-third of rents (deemed by Hospira to be representative of theinterest factor inherent in rents), interest expense and interest capitalized,net of amortization.  “Fixed charges”consist of one-third of rents, interest expense and interest capitalized.

 

----
COURT OF APPEALS FOR THE

FIRST DISTRICT OF TEXAS AT HOUSTON

ORDER ON MOTION

November 7, 2008 Revision

Cause number: 01-15-00266-CV

Style: Unocal Pipeline Co. v. BP Pipelines (Alaska) Inc., ConocoPhillips 

Transportation Alaska, Inc. and ExxonMobil Pipeline Co.

Date motions filed*: September 3, 2015

Type of motions: Motions to Appear Pro Hac Vice by Lara E. Romansic and Steven G. 

Reed

Parties filing motions: Appellees BP Pipelines (Alaska) Inc., ConocoPhillips Transportation

Alaska, Inc., and ExxonMobil Pipeline Co.

Document to be filed: N/A

Is appeal accelerated? No.

Ordered that motions are:

 Granted

 Denied

 Dismissed (e.g., want of jurisdiction, moot)

 Other: _____________________________________ 

The motions to appear pro hac vice by non-resident attorneys Lara E. Romansic and

Steven G. Reed are denied without prejudice to refiling with the required motions in 

support by a Texas resident attorney. See TEX. RULES GOVERN. BAR ADM’N, RULE

XIX(b) (2015) (“The motion of the non-resident attorney seeking permission to 

participate in Texas proceedings must be accompanied by motion of the resident 

practicing Texas attorney with whom the non-resident attorney will be associated in the 

proceeding of a particular cause. . . .”).

Judge's signature: /s/ Evelyn V. Keyes

 

Date: February 15, 2015
Exhibit 32.1



CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER



In connection with the accompanying Amendment No. 5 to the Annual Report on Form 10-K/A for the year ended December 31, 2003 (the
Periodic Report), I, Dan F. Smith, Chief Executive Officer of Millennium Chemicals Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. Section 78m or 78o(d)); and
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Millennium Chemicals Inc..
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |                        
|----------------------- |  | -----------------------
|Date: February 14, 2005 |  | /s/ Dan F. Smith       
|                        |  | Dan F. Smith           
|                        |  | Chief Executive Officer



A signed original of this written
statement required by Section 906 has been provided to Millennium Chemicals Inc. and will be retained by Millennium Chemicals Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 23.2



                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
                   -----------------------------------------

     We consent to the incorporation by reference in the Registration
Statements on Forms S-3 (Nos. 333-38309, 333-36189, 333-44985, 333-55775, 333-
66793, 333-80617, and 333-87067) and S-8 (Nos. 333-16385, 333-35937, 333-39796,
333-56171, 333-75945, and 333-87426) of QuadraMed Corporation of our report
relating to the consolidated balance sheet and the consolidated statements of
operations and comprehensive loss, stockholders' equity, and cash flows of
QuadraMed Corporation, dated March 28, 2003 and May 15, 2003 (as to the first
paragraph of note 25), appearing on Form 10-K/A for the fiscal year ended
December 31, 2001, and the related financial statement schedule, which report
appears in the December 31, 2002 annual report on Form 10-K of QuadraMed
Corporation.



                                                   /s/  Pisenti & Brinker LLP
                                                   ----------------------------
                                                   PISENTI & BRINKER LLP


Petaluma, California
August 11, 2003


                                       1
<PAGE>
 
            STATEMENT REGARDING COMPUTATION OF PER SHARE EARNINGS 

        The Conversion was effective December 20, 1996.  Accordingly, earnings 
per share data for the year ended June 30, 1997 is comprised of the earnings for
the post-Conversion period.  The weighted average number of shares outstanding 
includes all shares issued and outstanding of 407,330 less 32,586 shares 
purchased by the ESOP at the time of the Conversion plus the pro-rata portion of
shares committed to be released through June 30, 1997.


Net income for the period from December 20, 1996 to June 30, 1997     $926,914

Weighted average number of shares outstanding                         $375,627

Earnings per share                                                       $2.47
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5061 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5061

              To suspend temporarily the duty on Oryzalin.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 17, 2008

  Mr. Sestak introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
              To suspend temporarily the duty on Oryzalin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ORYZALIN.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00      4-(dipropylanimo)-  Free         No change        No change        On or before 12/  ''.
                         3,5-                                                               31/2011
                         dinitrobenzenesul
                         fonamide
                         (Oryzalin) (CAS
                         No. 19044-88-3)
                         (provided for in
                         subheading
                         2935.00.95)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Exhibit 21.1



SUBSIDIARIES



Information relating to the subsidiaries of QuadraMed as of January 1, 2009 is set forth below. All of the indicated subsidiaries are directly or
indirectly wholly owned by QuadraMed.



|                                     |  |                                              
|------------------------------------ |  | ---------------------------------------------
|Name of Subsidiary                   |  | Jurisdiction of Incorporation or Organization
|QuadraMed Affinity Corporation       |  | Delaware                                     
|Tempus Software LLC                  |  | Delaware                                     
|QuadraMed International Pty. Limited |  | Australia                                    
|QuadraMed International Limited      |  | United Kingdom                               
|QuadCopper LLC                       |  | Delaware                                     
|QuadraMed Europe Limited             |  | United Kingdom                               
|QuadraMed Canada Corporation         |  | Canada
VIA EDGAR 
 
 
 
 
 
								January 31, 1997 
 
 
 
 
Securities and Exchange Commission 
Judiciary Plaza 
450 Fifth Street, NW 
Washington, DC 20549 
 
 
 
ATTN:		Office of Filings, Information and Consumer Services 
 
 
RE:		Smith Barney Natural Resources Fund Inc. (the "Fund") 
		File Nos. 33-7339 and 811-4757 
 
 
Gentlemen: 
 
	Please be advised that today January 31, 1997, I erroneously filed 
a  
497j for the above- captioned 
 
fund, as Accession Number 91155-97-000062.  Please withdraw/delete this 
filing  
since it was done in  
 
error.  Thank you. 
 
 
 
								Very truly yours, 
 
 
								Jacqueline Carr 
								Assistant Vice President
<PAGE>   1
                                                                   EXHIBIT 23.2

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in Registration Statements No.
333-16385 and 333-35937 of Quadramed Corporation on Forms S-8 of our report
dated April 25, 1997 (relating to the financial statements of FRA Acquisitions,
Inc. not presented separately herein) appearing in this Annual Report on Form
10-K of Quadramed Corporation for the year ended December 31, 1997.

/s/ DELOITTE & TOUCHE LLP

DELOITTE & TOUCHE LLP
Los Angeles, California
April 20, 1998
EXHIBIT
      32.2





CERTIFICATION
                REQUIRED BY 18 U.S.C. SECTION 1350(AS
                ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
                2002)





I,
      William S. Creekmuir, as Chief Financial Officer of Simmons Company (the
“Company”), certify, pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to
      Section 906 of the Sarbanes-Oxley Act of 2002), that to my
      knowledge:





(1)
      the Quarterly Report on Form 10-Q of the Company for the quarter ended June
      30,
      2007 (the “Report”), being filed with the U.S. Securities and Exchange
      Commission on the date hereof, fully complies with the requirements of Section
      13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
      and





(2)
      the information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





Date:  August
      14, 2007 /s/
      William S. Creekmuir


Name: William S. Creekmuir


Title: Chief Financial Officer











A
      signed original of this written statement required by Section 906 has been
      provided to Simmons Company and will be retained by Simmons Company and
      furnished to the Securities and Exchange Commission or its staff upon
      request.
# Official Journal C 196A/2013

| | ISSN 1977-091X
  doi:10.3000/1977091X.CA2013.196.eng |
| --- | --- |
| Official Journal
  of the European Union | C 196A |
| | |
| English edition | Information and Notices | Volume 569 July 2013 |

ISSN 1977-091X

doi:10.3000/1977091X.CA2013.196.eng

Official Journal

of the European Union

C 196A

English edition

Information and Notices

Volume 569 July 2013

---

| Notice No | Contents | page |
| --- | --- | --- |
| | V   Announcements |
| | ADMINISTRATIVE PROCEDURES |
| | Committee of the Regions |
| 2013/C 196A/01 | Recruitment notice No CDR/SG/AD16/15/13 concerning a post of Secretary-General (m/f) in the Secretariat-General of the Committee of the Regions (Recruitment grade AD16/3) — Publication under Article 2(a) and Article 8 of the Conditions of Employment of Other Servants of the European Union (CEOS) | 1 |

Notice No

Contents

page

V   Announcements

ADMINISTRATIVE PROCEDURES

Committee of the Regions

2013/C 196A/01

Recruitment notice No CDR/SG/AD16/15/13 concerning a post of Secretary-General (m/f) in the Secretariat-General of the Committee of the Regions (Recruitment grade AD16/3) — Publication under Article 2(a) and Article 8 of the Conditions of Employment of Other Servants of the European Union (CEOS)

Publication under Article 2(a) and Article 8 of the Conditions of Employment of Other Servants of the European Union (CEOS)

1

---

REVIEW OF COMPETITION C A OJs

Please find below the list of C A published during the present year.

Unless otherwise indicated, OJs are published in all language versions.

| 5 | |
| --- | --- |
| 27 | (RO) |
| 29 | |
| 33 | |
| 34 | |
| 36 | (DA) |
| 41 | (BG) |
| 43 | (EN) |
| 49 | (ET) |
| 50 | (HU) |
| 51 | (SL) |
| 54 | (DE/EN/FR) |
| 58 | (EN/GA) |
| 75 | |
| 81 | |
| 82 | |
| 88 | (BG) |
| 89 | (CS) |
| 94 | |
| 104 | |
| 109 | |
| 111 | |
| 112 | (DE/EN/FR) |
| 117 | (ET) |
| 118 | |
| 120 | |
| 131 | |
| 143 | |
| 160 | (DE/EN/FR) |
| 162 | |
| 166 | |
| 167 | |
| 168 | |
| 172 | |
| 173 | |
| 174 | |
| 176 | (BG/DE/EN/ET/FI/IT/LT/LV/MT/NL/PL/PT/SK/SL/SV) |
| 180 | (MT) |
| 182 | (DE/EN/FR) |
| 183 | (IT) |
| 191 | |
| 192 | |
| 193 | |
| 194 | |
| 196 | |

5

27

(RO)

29

33

34

36

(DA)

41

(BG)

43

(EN)

49

(ET)

50

(HU)

51

(SL)

54

(DE/EN/FR)

58

(EN/GA)

75

81

82

88

(BG)

89

(CS)

94

104

109

111

112

(DE/EN/FR)

117

(ET)

118

120

131

143

160

(DE/EN/FR)

162

166

167

168

172

173

174

176

(BG/DE/EN/ET/FI/IT/LT/LV/MT/NL/PL/PT/SK/SL/SV)

180

(MT)

182

(DE/EN/FR)

183

(IT)

191

192

193

194

196

| EN | |
| --- | --- |

EN
<PAGE>
                                                                               .
                                                                               .
                                                                               .

                                                                    EXHIBIT 11.1

                           COAST DENTAL SERVICES, INC.
                    COMPUTATION OF PER SHARE EARNINGS (LOSS)

<TABLE>
<CAPTION>
                                                                                     YEAR ENDED DECEMBER 31,
                                                                      --------------------------------------------------
                                                                          2003                2002              2001
                                                                          ----                ----              ----
<S>                                                                   <C>                <C>              <C>
Net loss..........................................................    $   (2,986,409)    $   (3,943,797)  $   (9,366,661)
                                                                      ==============     ==============   ==============

Shares:
Basic weighted average number of shares outstanding...............         2,110,583          2,091,223        2,091,223
Additional shares issuable under stock options for
  diluted earnings per share......................................                 -                  -                -
                                                                      --------------     --------------   --------------
Diluted weighted average number of shares outstanding.............         2,110,583          2,091,223        2,091,223
                                                                      ==============     ==============   ==============

Basic loss per share:
     Net loss.....................................................    $        (1.41)    $        (1.89)  $        (4.48)
                                                                      ==============     ==============   ==============
Diluted loss per share:
     Net loss.....................................................    $        (1.41)    $        (1.89)  $        (4.48)
                                                                      ==============     ==============   ==============
</TABLE>
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5010 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5010

      To extend the temporary suspension of duty on Clothianidin.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 16, 2008

Mrs. Tauscher introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
      To extend the temporary suspension of duty on Clothianidin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CLOTHIANIDIN.

    (a) In General.--Heading 9902.10.84 of the Harmonized Tariff 
Schedule of the United States is amended by striking ``12/31/2009'' and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4998 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 4998

  To extend the temporary suspension of duty on mixtures of methyl 4-
   iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] 
     benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and 
                         application adjuvants.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 16, 2008

Mr. Neugebauer introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To extend the temporary suspension of duty on mixtures of methyl 4-
   iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] 
     benzoate, sodium salt (Iodosulfuron methyl, sodium salt) and 
                         application adjuvants.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF METHYL 4-IODO-2-[3-(4-METHOXY-6-METHYL-1,3,5-
              TRIAZIN-2-YL)UREIDOSULFONYL] BENZOATE, SODIUM SALT 
              (IODOSULFURON METHYL, SODIUM SALT) AND APPLICATION 
              ADJUVANTS.

    (a) In General.--Heading 9902.11.44 of the Harmonized Tariff 
Schedule of the United States (relating to mixtures of methyl 4-iodo-2-
[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl] benzoate, 
sodium salt (Iodosulfuron methyl, sodium salt) and application 
adjuvants) is amended by striking ``12/31/2009'' and inserting ``12/31/
2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```